Cell and gene therapies, or CGT, have come a long way since they were first introduced. In the last few decades, both cell therapy -- the...
Vous n'êtes pas connecté
Maroc - ONCOLOGYNEWS.COM.AU - A La Une - 19/11/2024 13:53
In recent years, scientists have created a range of new methods based on CRISPR-Cas technology for precisely editing the genetic material of living organisms. One application is in cell therapy: a patient’s immune cells can be specifically reprogrammed to fight cancer more effectively. Researchers in the Department of Biosystems Science and Engineering at ETH Zurich [...]
Cell and gene therapies, or CGT, have come a long way since they were first introduced. In the last few decades, both cell therapy -- the...
Creative Biolabs provides end-to-end scientific support—from liposomal formulation design to next-generation LNP platforms tailored for CRISPR-Cas9,...
Creative Biolabs provides end-to-end scientific support—from liposomal formulation design to next-generation LNP platforms tailored for CRISPR-Cas9,...
A team led by investigators at Mass General Brigham and Dana-Farber Cancer Institute, USA, has shown that a single injection of an oncolytic virus—a...
A team led by investigators at Mass General Brigham and Dana-Farber Cancer Institute, USA, has shown that a single injection of an oncolytic virus—a...
For almost 60 years, scientists have tried to understand why DNA doesn’t replicate wildly and uncontrollably every time a cell divides, which it...
For almost 60 years, scientists have tried to understand why DNA doesn’t replicate wildly and uncontrollably every time a cell divides, which it...
UCLA researchers have developed a lipid nanoparticle-based gene-editing approach capable of inserting an entire healthy gene into human airway cells,...
In a lab-grown cell study focused on potential new treatment targets for halting the spread of most pancreatic cancers, Johns Hopkins Medicine...
In a lab-grown cell study focused on potential new treatment targets for halting the spread of most pancreatic cancers, Johns Hopkins Medicine...